協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2015/03/18 | 1,550 | 1,566 | 1,543 | 1,555 | +6 | +0.4% | 989,000 |
| 2015/03/17 | 1,550 | 1,567 | 1,540 | 1,549 | +20 | +1.3% | 1,260,000 |
| 2015/03/16 | 1,516 | 1,535 | 1,504 | 1,529 | +11 | +0.7% | 1,421,000 |
| 2015/03/13 | 1,535 | 1,535 | 1,498 | 1,518 | -25 | -1.6% | 3,992,000 |
| 2015/03/12 | 1,535 | 1,551 | 1,533 | 1,543 | -1 | -0.1% | 1,276,000 |
| 2015/03/11 | 1,550 | 1,555 | 1,530 | 1,544 | +2 | +0.1% | 952,000 |
| 2015/03/10 | 1,558 | 1,568 | 1,533 | 1,542 | -10 | -0.6% | 1,134,000 |
| 2015/03/09 | 1,568 | 1,580 | 1,546 | 1,552 | -31 | -2% | 1,047,000 |
| 2015/03/06 | 1,571 | 1,606 | 1,563 | 1,583 | +11 | +0.7% | 3,159,000 |
| 2015/03/05 | 1,503 | 1,573 | 1,503 | 1,572 | +56 | +3.7% | 1,688,000 |
| 2015/03/04 | 1,497 | 1,520 | 1,478 | 1,516 | +19 | +1.3% | 1,302,000 |
| 2015/03/03 | 1,475 | 1,499 | 1,469 | 1,497 | +64 | +4.5% | 2,102,000 |
| 2015/03/02 | 1,441 | 1,453 | 1,431 | 1,433 | -12 | -0.8% | 832,000 |
| 2015/02/27 | 1,455 | 1,455 | 1,440 | 1,445 | +1 | +0.1% | 1,159,000 |
| 2015/02/26 | 1,450 | 1,454 | 1,431 | 1,444 | -24 | -1.6% | 1,513,000 |
| 2015/02/25 | 1,450 | 1,472 | 1,445 | 1,468 | +36 | +2.5% | 1,378,000 |
| 2015/02/24 | 1,429 | 1,432 | 1,417 | 1,432 | +12 | +0.8% | 877,000 |
| 2015/02/23 | 1,410 | 1,428 | 1,399 | 1,420 | +24 | +1.7% | 942,000 |
| 2015/02/20 | 1,404 | 1,405 | 1,382 | 1,396 | ±0 | ±0% | 1,198,000 |
| 2015/02/19 | 1,377 | 1,400 | 1,376 | 1,396 | +8 | +0.6% | 1,119,000 |
| 2015/02/18 | 1,392 | 1,398 | 1,376 | 1,388 | +4 | +0.3% | 1,301,000 |
| 2015/02/17 | 1,387 | 1,392 | 1,380 | 1,384 | -16 | -1.1% | 937,000 |
| 2015/02/16 | 1,406 | 1,412 | 1,386 | 1,400 | -6 | -0.4% | 858,000 |
| 2015/02/13 | 1,417 | 1,423 | 1,396 | 1,406 | -12 | -0.8% | 1,969,000 |
| 2015/02/12 | 1,380 | 1,424 | 1,375 | 1,418 | +63 | +4.6% | 2,092,000 |
| 2015/02/10 | 1,362 | 1,377 | 1,341 | 1,355 | -19 | -1.4% | 1,460,000 |
| 2015/02/09 | 1,372 | 1,380 | 1,364 | 1,374 | +10 | +0.7% | 942,000 |
| 2015/02/06 | 1,350 | 1,368 | 1,339 | 1,364 | +24 | +1.8% | 1,082,000 |
| 2015/02/05 | 1,350 | 1,356 | 1,331 | 1,340 | -8 | -0.6% | 1,525,000 |
| 2015/02/04 | 1,360 | 1,363 | 1,338 | 1,348 | -6 | -0.4% | 2,389,000 |
| 2015/02/03 | 1,368 | 1,374 | 1,346 | 1,354 | +2 | +0.1% | 2,136,000 |
| 2015/02/02 | 1,341 | 1,372 | 1,340 | 1,352 | +4 | +0.3% | 1,851,000 |
| 2015/01/30 | 1,346 | 1,360 | 1,332 | 1,348 | +12 | +0.9% | 2,114,000 |
| 2015/01/29 | 1,325 | 1,347 | 1,315 | 1,336 | -7 | -0.5% | 1,527,000 |
| 2015/01/28 | 1,305 | 1,353 | 1,301 | 1,343 | +36 | +2.8% | 2,566,000 |
| 2015/01/27 | 1,269 | 1,307 | 1,264 | 1,307 | +85 | +7% | 3,039,000 |
| 2015/01/26 | 1,207 | 1,224 | 1,204 | 1,222 | +11 | +0.9% | 1,381,000 |
| 2015/01/23 | 1,220 | 1,220 | 1,202 | 1,211 | +1 | +0.1% | 1,671,000 |
| 2015/01/22 | 1,200 | 1,211 | 1,193 | 1,210 | +11 | +0.9% | 1,731,000 |
| 2015/01/21 | 1,186 | 1,200 | 1,181 | 1,199 | -1 | -0.1% | 1,698,000 |
| 2015/01/20 | 1,171 | 1,201 | 1,169 | 1,200 | +29 | +2.5% | 1,561,000 |
| 2015/01/19 | 1,148 | 1,172 | 1,146 | 1,171 | +42 | +3.7% | 1,620,000 |
| 2015/01/16 | 1,129 | 1,135 | 1,110 | 1,129 | -26 | -2.3% | 1,866,000 |
| 2015/01/15 | 1,119 | 1,158 | 1,119 | 1,155 | +41 | +3.7% | 1,827,000 |
| 2015/01/14 | 1,131 | 1,141 | 1,111 | 1,114 | -41 | -3.5% | 1,719,000 |
| 2015/01/13 | 1,133 | 1,155 | 1,131 | 1,155 | +16 | +1.4% | 1,437,000 |
| 2015/01/09 | 1,150 | 1,151 | 1,129 | 1,139 | +1 | +0.1% | 1,766,000 |
| 2015/01/08 | 1,109 | 1,144 | 1,109 | 1,138 | +39 | +3.5% | 1,455,000 |
| 2015/01/07 | 1,096 | 1,109 | 1,094 | 1,099 | -2 | -0.2% | 1,003,000 |
| 2015/01/06 | 1,120 | 1,124 | 1,101 | 1,101 | -32 | -2.8% | 1,693,000 |
2551～
2600
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 263,900円 | -3.5% | -11.3% | 2.27% | 24.24倍 | 1.64倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 169,200円 | +0.9% | +380.2% | 4.61% | 23.31倍 | 2.00倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 258,000円 | +20.9% | +10.6% | 2.56% | 12.20倍 | 1.61倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 467,600円 | +0.1% | -3.4% | 3.42% | 31.79倍 | 1.57倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 166,100円 | +0.6% | +43.3% | 4.82% | 11.65倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
